Expertise in
10
conditions

Dr. Elmer Lehman

Obstetrics and Gynecology
Marshfield Medical Center-Marshfield Medical Offices-Obstetrics & Gynecology
1000 N Oak Ave, 
Marshfield, WI 
Expertise in
10
conditions
Marshfield Medical Center-Marshfield Medical Offices-Obstetrics & Gynecology
1000 N Oak Ave, 
Marshfield, WI 

Overview

Elmer Lehman is an Obstetrics and Gynecologist practicing medicine in Marshfield, Wisconsin.

Dr. Lehman is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Vulvar Cancer, and Bladder Reconstruction.

He is actively involved in clinical research, participating in 5 clinical trials.

Graduate Institution

Medical College Of Wisconsin

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in WI

Hospital Affiliations

Marshfield Medical Center - Weston
Marshfield Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Marshfield Medical Center-Marshfield Medical Offices-Obstetrics & Gynecology
1000 N Oak Ave, Marshfield, WI 54449

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Drug, Procedure, Biological
Study Phase: Phase 2
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Radiation, Drug, Other
Study Drugs: Cisplatin, Triapine
Study Phase: Phase 3
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Drug, Procedure, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 3
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 01, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
1
conditions
Dr. Maria Mascola
Obstetrics and Gynecology
Expertise in
1
conditions
Dr. Maria Mascola
Obstetrics and Gynecology
Referral may be required

MCHS Hospitals Inc.

1000 N Oak Ave, 
Marshfield, WI 
 (0.1 miles away)
715-387-5511
Languages Spoken:
English
See accepted insurances

Maria Mascola is an Obstetrics and Gynecologist practicing medicine in Marshfield, Wisconsin. Dr. Mascola is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Methimazole Antenatal Exposure.

Expertise in
3
conditions
Dr. Tiffany Casper
Obstetrics and Gynecology
Expertise in
3
conditions
Dr. Tiffany Casper
Obstetrics and Gynecology
Referral may be required

Mayo Clinic Health System-Southwest Wisconsin Region Inc.

325 Butts Ave, 
Tomah, WI 
 (50.7 miles away)
608-372-5951
Languages Spoken:
English
See accepted insurances

Tiffany Casper is a primary care provider, practicing in Obstetrics and Gynecologist in Tomah, Wisconsin. Dr. Casper is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Gitelman Syndrome, Hypothyroidism, Obesity in Children, and Melorheostosis with Osteopoikilosis.

Expertise in
1
conditions
Dr. Leah Becicka
Obstetrics and Gynecology
Expertise in
1
conditions
Dr. Leah Becicka
Obstetrics and Gynecology
Referral may be required

Aspirus Medford Hospital & Clinics

135 S Gibson St, 
Medford, WI 
 (32.9 miles away)
715-748-8100
Languages Spoken:
English
See accepted insurances

Leah Becicka is an Obstetrics and Gynecologist practicing medicine in Medford, Wisconsin. Dr. Becicka is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Uterine Prolapse, Cervical Dysplasia, Menorrhagia, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT).

Frequently Asked Questions about Dr. Elmer Lehman

How do I make an appointment with Dr. Elmer Lehman?

You can book an appointment with Dr. Elmer Lehman by calling their office at 715-387-5161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elmer Lehman a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elmer Lehman is classified as an Advanced expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elmer Lehman specialize in?

While Dr. Elmer Lehman is a Obstetrics and Gynecology, they have specific expertise in Endometrial Cancer, Endometrial Stromal Sarcoma, and Malignant Mixed Mullerian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Elmer Lehman accept my insurance?

Dr. Elmer Lehman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 715-387-5161 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lehman's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile